IL24 and familial pancreatic carcinoma: In another study, synergistic activity between geldanamycin (GA), an Hsp90 inhibitor, and IL‐24 was shown in pancreatic cancer cells, although the underlying mechanism contributing to this effect remains unclear (Zhang et al. 2013).